The one blood marker that predicts heart attack 10 years early

The blood marker worth knowing is apolipoprotein B, usually shortened to ApoB. It does not predict the exact day someone will have a heart attack, but it can reveal a higher number of artery-damaging particles years before symptoms appear, especially when LDL cholesterol looks reassuring. In the UK it should be interpreted alongside QRISK3, blood pressure, smoking, diabetes, family history and the full lipid panel, not used as a stand-alone diagnosis.¹⁵

What ApoB actually measures

Every LDL, VLDL, IDL and lipoprotein(a) particle carries one ApoB molecule. That makes ApoB a practical proxy for the number of atherogenic particles circulating in your blood. Those particles matter because atherosclerosis is driven by particles crossing into the artery wall, becoming retained, and triggering inflammation over time.

LDL cholesterol is still important. It tells you how much cholesterol is being carried in LDL particles. But two people can have the same LDL cholesterol and different particle numbers. One person may have fewer cholesterol-rich particles. Another may have many smaller cholesterol-poor particles. ApoB helps distinguish those situations.

This is why ApoB often becomes interesting when standard results look "not too bad" but the person has belly fat, high triglycerides, low HDL cholesterol, fatty liver, prediabetes, polycystic ovary syndrome, type 2 diabetes, sleep apnoea or a strong family history of early heart disease. Those patterns can create discordance: the cholesterol cargo looks acceptable, but the particle count is higher than expected.

Why ApoB can flag risk early

Heart attacks usually do not come from a sudden problem that began last month. Plaque builds over years. The earlier you identify the drivers, the more time you have to change the slope of risk. ApoB is useful because it reflects cumulative exposure to atherogenic particles, not just a single snapshot of cholesterol carried inside them.

A 2025 UK Biobank analysis reported that ApoB outperformed LDL particle number as a marker of cardiovascular risk in that cohort.¹ A JAMA Cardiology study also found that risk of myocardial infarction related strongly to ApoB-containing lipoproteins, supporting the idea that the number of atherogenic particles is central to risk.²

The early-warning value is clearest when results are discordant. In the CARDIA study, ApoB and LDL cholesterol discordance in young adults predicted later coronary artery calcification, a marker of atherosclerosis.³ In MESA, ApoB discordance with LDL cholesterol and non-HDL cholesterol was also studied in relation to coronary artery calcification.⁴ These studies do not mean ApoB alone decides treatment. They show why a normal LDL cholesterol can sometimes miss risk.

ApoB vs LDL cholesterol vs non-HDL cholesterol

Standard UK cholesterol panels usually include total cholesterol, HDL cholesterol, non-HDL cholesterol and sometimes LDL cholesterol. Non-HDL cholesterol is total cholesterol minus HDL cholesterol, so it captures cholesterol carried by all non-HDL atherogenic particles. It is useful, cheap and widely available.

ApoB answers a slightly different question. It asks how many atherogenic particles are present, not how much cholesterol they carry. This can be especially helpful when triglycerides are high or insulin resistance is present, because particle composition can shift. A person can have "average" LDL cholesterol but too many ApoB particles.

If you want the deeper physiology, the ApoB and lipid panel guide explains why ApoB, LDL cholesterol and non-HDL cholesterol can point in different directions.

Who should consider testing

ApoB is not necessary for every healthy 25-year-old. It is most useful when your standard cholesterol result does not seem to match the rest of your risk picture. Consider discussing it if you have a strong family history of early heart attack or stroke, premature high cholesterol, type 2 diabetes, prediabetes, metabolic syndrome, high triglycerides, fatty liver, PCOS, chronic kidney disease, autoimmune inflammatory disease, or a previous "normal" cholesterol result despite obvious risk factors.

It can also help people who are already making big changes. If weight loss, training, a low-carbohydrate diet, thyroid treatment, menopause treatment or a new medicine changes LDL cholesterol, triglycerides and HDL cholesterol in different directions, ApoB can clarify whether the atherogenic particle burden improved or worsened.

In the UK, cardiovascular prevention is usually based on QRISK3, which estimates 10-year cardiovascular risk using factors such as age, sex, ethnicity, smoking, diabetes, blood pressure, cholesterol ratio and other clinical variables.⁶ NICE lipid guidance uses this kind of risk assessment to guide statin discussions and primary prevention decisions.⁵ ApoB may add useful detail, but it does not replace the whole-person risk calculation.

Use the metabolic syndrome guide and insulin resistance guide if your lipids are part of a wider pattern of belly fat, high blood pressure, high glucose, high triglycerides or low HDL cholesterol.

What to do with a high result

A high ApoB result should lead to a risk conversation, not a crash diet. The first step is to confirm the full picture: blood pressure, smoking, HbA1c, kidney function, thyroid status if relevant, family history, lipoprotein(a), standard lipids and QRISK3. NHS high cholesterol guidance explains that high cholesterol itself usually has no symptoms and is identified through a blood test.⁷

Then ask what can be changed. The biggest levers are stopping smoking, treating high blood pressure, improving insulin resistance, reducing saturated fat if LDL or ApoB is high, increasing soluble fibre, losing excess visceral fat, improving sleep apnoea, reducing alcohol if triglycerides are high, and using lipid-lowering medication when the risk-benefit balance supports it. The answer depends on your whole risk profile, not one number.

There are also important false reassurances to avoid. A low resting heart rate does not cancel high ApoB. A good VO2 max does not erase inherited lipid risk. A healthy weight does not rule out high lipoprotein(a). A "clean" diet does not guarantee low particle burden. Blood markers are useful because they can contradict the story you want to believe.

Also avoid treating ApoB as an emergency marker. Chest pain, pressure, breathlessness, fainting, stroke symptoms or sudden severe symptoms need urgent assessment regardless of cholesterol results. ApoB is mainly a prevention marker: it helps you act years earlier, before plaque becomes a crisis.

If you are ordering private blood tests, do not collect numbers without a plan. Use Start here to prepare the conversation, and use the stack builder to list supplements, statins, blood-pressure medicines or diabetes drugs before asking for interpretation.

This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.